An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Investigational Drug Acquiring Traction Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where communities with thousands of members share comparison images, administration instructions and claims of rapid British shipping. Vendors promote the drug there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Worries
However, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.
Several experts said the popularity for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, risking penalties, legal action or imprisonment.
Platform Reaction and Content Removal
According to TikTok, the service has taken down violative material and banned related keywords and search suggestions. The company stated it was committed to keeping the platform safe and allocating resources in enhancing compliance measures.
Online Marketplace Activities
Research also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or administering at home.
Within moments of joining one group, a seller shared WhatsApp details, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.
Product Details and Costs
Within these groups, messages display dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how long a injector should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A representative for the messaging service said it actively monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has previously encountered patients injured by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may subject users to potentially serious medical dangers”.
